Roivant Sciences Ltd. Common Shares vs Ventas Inc. Common Stock — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B), while Ventas Inc. Common Stock trades at $82.53 (market cap $41.06B). The key difference: Ventas Inc. Common Stock is the larger of the two by market cap, and Ventas Inc. Common Stock pays a 2.6% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and Ventas Inc. Common Stock for 0 Days on average.
| ROIV | VTR | |
|---|---|---|
Market Cap | $25.09B | $41.06B |
Volume | 5,738,571 | 4,174,820 |
Sector | Health | Real Estate |
52-Week High | $41.81 | $100.53 |
52-Week Low | $16.04 | $67.45 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $21.36B | $53.78B |
Dividend Yield | — | 2.6% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →Ventas is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, medical office buildings, and research-related facilities.
Read more on VTR →